Compare RGEN & PRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RGEN | PRI |
|---|---|---|
| Founded | 1981 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.3B |
| IPO Year | N/A | N/A |
| Metric | RGEN | PRI |
|---|---|---|
| Price | $163.80 | $254.49 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 5 |
| Target Price | $170.90 | ★ $303.40 |
| AVG Volume (30 Days) | ★ 778.3K | 187.4K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | N/A | ★ 65.97 |
| EPS | 0.03 | ★ 21.75 |
| Revenue | $707,890,000.00 | ★ $3,335,204,000.00 |
| Revenue This Year | $17.84 | $4.64 |
| Revenue Next Year | $12.57 | $4.73 |
| P/E Ratio | $6,437.16 | ★ $11.70 |
| Revenue Growth | ★ 11.74 | 10.41 |
| 52 Week Low | $102.97 | $230.98 |
| 52 Week High | $182.52 | $298.75 |
| Indicator | RGEN | PRI |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 46.27 |
| Support Level | $160.11 | $249.89 |
| Resistance Level | $170.40 | $256.87 |
| Average True Range (ATR) | 5.38 | 5.29 |
| MACD | -0.85 | -0.06 |
| Stochastic Oscillator | 44.68 | 21.50 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.